오성용 교수 연구실
article|
bronze
·인용수 9
·2023
1523P Phase II dose optimization results from MOUNTAINEER-02: A study of tucatinib, trastuzumab, ramucirumab, and paclitaxel for HER2+ gastroesophageal cancer (GEC)
Mustapha Tehfé, J. Lee, Sun Young Rha, Yoshiaki Nakamura, Josep Tabernero, Kohei Shitara, D-Y. Oh, Jennifer R. Eads, J. Marshall, Zev A. Wainberg, Kyung-Woo Lee, Y-K. Kang, C-Y. Liao, Sung Yong Oh, Kun‐Huei Yeh, Donald Richards, Michelle Ubowski, K. Zhao, S. Bhaumik, John H. Strickler
IF 56.7Annals of Oncology
키워드
RamucirumabMedicinePaclitaxelTrastuzumabInternal medicineOncologyCancerBreast cancer